Rock Springs Capital Management LP Inozyme Pharma, Inc. Transaction History
Rock Springs Capital Management LP
- $2.51 Billion
- Q4 2024
A detailed history of Rock Springs Capital Management LP transactions in Inozyme Pharma, Inc. stock. As of the latest transaction made, Rock Springs Capital Management LP holds 3,861,983 shares of INZY stock, worth $4.9 Million. This represents 0.43% of its overall portfolio holdings.
Number of Shares
3,861,983
Previous 3,802,883
1.55%
Holding current value
$4.9 Million
Previous $19.9 Million
46.22%
% of portfolio
0.43%
Previous 0.68%
Shares
16 transactions
Others Institutions Holding INZY
# of Institutions
104Shares Held
50.7MCall Options Held
2.6KPut Options Held
5.1K-
Adage Capital Partners Gp, L.L.C. Boston, MA5.16MShares$6.55 Million0.03% of portfolio
-
Pivotal Bio Venture Partners Investment Advisor LLC San Francisco, CA4.49MShares$5.71 Million11.45% of portfolio
-
Sofinnova Investments, Inc. Menlo Park, CA4.28MShares$5.44 Million0.97% of portfolio
-
Affinity Asset Advisors, LLC New York, NY3.97MShares$5.04 Million1.97% of portfolio
-
Black Rock Inc. New York, NY3.34MShares$4.25 Million0.0% of portfolio
About Inozyme Pharma, Inc.
- Ticker INZY
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 40,145,700
- Market Cap $51M
- Description
- Inozyme Pharma, Inc., a rare disease biopharmaceutical company, engages in developing therapeutics for treating abnormal mineralization impacting the vasculature, soft tissue, and skeleton diseases. The company's lead product candidate is INZ-701, a soluble, recombinant protein to treat the rare genetic diseases of ENPP1 and ABCC6 deficiencies, ...